PortViewPortView
Histogen logo

Histogen (HSTO) Stock Analysis

NASDAQHealthcareBiotechnology

$0.02
1-year price historyRange $0.02 – $0.05

What Histogen does

Histogen Inc. operates as a clinical-stage biotechnology company, focusing on the development of novel, stem cell-free biologic products derived from its proprietary hypoxia-generated growth factor technology platform. Among its offerings is HST-003, a human extracellular matrix, currently undergoing Phase 1/2 clinical trials to mend articular cartilage defects in the knee. Additionally, the company is advancing HST-004, a cell-conditioned media solution designed for spinal disc repair, and Emricasan, an orally active pan-caspase inhibitor targeting COVID-19 treatment. In its preclinical pipeline, Histogen is developing CTS-2090 and CTS-2096. These are selective caspase-1 inhibitors formulated to suppress inflammasome activation and intervene in a range of inflammation-mediated conditions. Founded in 2007, Histogen Inc. maintains its headquarters in San Diego, California.

Key metrics

Market cap
$85,435
P/E (TTM)
-0.01
EPS (TTM)
$-2.81
Beta
1.12
Dividend yield
0.00%
Revenue / share
$1.17
50-day avg
$0.00
200-day avg
$0.00
52-week high
$0.02
52-week low
$0.02
CEO
Susan A. Knudson

ETFs linked to HSTO

Broad-market and Healthcare sector ETFs an investor holding Histogen is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how HSTO fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze HSTO in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Histogen?
Histogen trades under the ticker HSTO on NASDAQ.
Which exchange is HSTO listed on?
HSTO is listed on NASDAQ.
What sector does Histogen operate in?
Histogen is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze HSTO in a portfolio?
PortView shows HSTO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.